Share this post on:

Product Name :
Sitafloxacin Hydrate

Search keywords :
Sitafloxacin (hydrate)

drugId :
null

Target Vo:
Topoisomerase IV

Target Vo Short Name :
Topoisomerase IV

Moa_Name:
Bacterial DNA gyrase inhibitors

First Approval Country :
Japan

First Approval Date Filter:
2008

Origin Company_Name :
Daiichi Sankyo Co Ltd

Active Company_Name :
Beijing Haitai Tianzheng Pharmaceutical Technology Co Ltd

Active Indication_Name:
Communicable Diseases

In Active Indication_Name:
Cystitis

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Rilotumumab Technical Information
Ifinatamab Cancer
EYFP Tag Antibody (YA872): EYFP Tag Antibody (YA872) is an unconjugated, mouse-derived, anti-EYFP Tag (YA872) monoclonal antibody. EYFP Tag Antibody (YA872) can be used for: WB expriments in species-independent background without labeling.

Share this post on:

Author: Interleukin Related